Angela R. Wateska

MedicineSocial SciencesMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? Α value of information analysis”.

Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? Α value of information analysis

Vaccine(2021)10.1016/j.vaccine.2021.05.037

N/A

0.241DataRank · unranked

4 citations

Mary Patricia Nowalk, Hawre Jalal, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner +3 more

Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis

Vaccine(2021)10.1016/j.vaccine.2021.06.037

N/A

0DataRank · unranked

3 citations

Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner +2 more

Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults

Vaccine(2023)10.1016/j.vaccine.2023.06.007

N/A

0DataRank · unranked

20 citations

Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman +2 more

Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older

Vaccine(2024)10.1016/j.vaccine.2024.04.002

N/A

0DataRank · unranked

16 citations

Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner +3 more

Cost-Effectiveness and Public Health Impact of 24-Valent Pneumococcal Conjugate Vaccine Compared With the Recommended Pneumococcal Vaccines in Older Adults

American Journal of Preventive Medicine(2024)10.1016/j.amepre.2024.11.014

N/A

0DataRank · unranked

8 citations

Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner +2 more

Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18–64 years of age

Vaccine(2024)10.1016/j.vaccine.2024.07.008

N/A

0DataRank · unranked

3 citations

Kenneth J. Smith, Jonathan M. Raviotta, Angela R. Wateska, Richard K. Zimmerman, Mary Patricia Nowalk

A budget impact analysis of 15- or 20- valent pneumococcal conjugate vaccine use in all US adults aged 50–64 years old compared to those with high-risk conditions from US payer perspective

BMC Public Health(2025)10.1186/s12889-025-22827-9

N/A

0DataRank · unranked

1 citations

Chyongchiou J. Lin, Angela R. Wateska, Richard K. Zimmerman, Kenneth J. Smith, Nirma Khatri Vadlamudi